This announcement is a separate document:
國藥科技股份：(1)建議股本重組；(2)關連交易：涉及根據關連特定授權發行普通股及可換股優先股之貸款資本化；(3)申請清洗豁免；(4)涉及根據特定授權發行可換股優先股之貸款資本化；及(5)建議修訂現有組織章程大綱及細則及採納新組織章程大綱及細則
SINOPHARM TECH: (1) PROPOSED CAPITAL REORGANISATION;(2) CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE;(3) APPLICATION FOR WHITEWASH WAIVER;(4) LOAN CAPITALISATION INVOLV
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.